HOME | Alphawatch

top of page

Stock Exchange

The Ondas Paradox (ONDS): Huge Growth. So Why Isn't the Stock Cooperating?

The Ondas Paradox (ONDS): Huge Growth. So Why Isn't the Stock Cooperating?

The Ondas Paradox (ONDS): Huge Growth. So Why Isn't the Stock Cooperating?

Jonathan Poyer

4 days ago2 min read

ORUKA (ORKA): 71% COMPLETE SKIN CLEARANCE AFTER TWO DOSES

ORUKA (ORKA): 71% COMPLETE SKIN CLEARANCE AFTER TWO DOSES

ORUKA (ORKA): 71% COMPLETE SKIN CLEARANCE AFTER TWO DOSES

Jonathan Poyer

Sep 253 min read

UiPath's (PATH) Act Two: From Robots to Orchestrating AI

UiPath's (PATH) Act Two: From Robots to Orchestrating AI

UiPath's (PATH) Act Two: From Robots to Orchestrating AI

Jonathan Poyer

Sep 232 min read

CELLDEX (CLDX) REPORTS POSITIVE PHASE 3 RESULTS FOR BARZOLVOLIMAB IN CSU

CELLDEX (CLDX) REPORTS POSITIVE PHASE 3 RESULTS FOR BARZOLVOLIMAB IN CSU

CELLDEX (CLDX) REPORTS POSITIVE PHASE 3 RESULTS FOR BARZOLVOLIMAB IN CSU

Jonathan Poyer

Sep 222 min read

Red Cat (RCAT) Goes to Sea

Red Cat (RCAT) Goes to Sea

Red Cat (RCAT) Goes to Sea

Jonathan Poyer

Sep 161 min read

Ondas (ONDS) Goes Deeper Into the Weapon System Acquiring Gate Technologies and Bron Technologies

Ondas (ONDS) Goes Deeper Into the Weapon System Acquiring Gate Technologies and Bron Technologies

Ondas (ONDS) Goes Deeper Into the Weapon System Acquiring Gate Technologies and Bron Technologies

Jonathan Poyer

Sep 161 min read

Bonds: Why Duration and Spreads Are Making Bonds Cool Again (Yes, Really)

Bonds: Why Duration and Spreads Are Making Bonds Cool Again (Yes, Really)

Bonds: Why Duration and Spreads Are Making Bonds Cool Again (Yes, Really)

Jonathan Poyer

Sep 161 min read

Why Smart Investors Are Locking Down Yields Before the Market Shifts

Why Smart Investors Are Locking Down Yields Before the Market Shifts

Why Smart Investors Are Locking Down Yields Before the Market Shifts

Jonathan Poyer

Sep 161 min read

DEFINIUM THERAPEUTICS (DFTX): ONE DOSE. THREE POSITIVE PHASE 3 READOUTS.

DEFINIUM THERAPEUTICS (DFTX): ONE DOSE. THREE POSITIVE PHASE 3 READOUTS.

DEFINIUM THERAPEUTICS (DFTX): ONE DOSE. THREE POSITIVE PHASE 3 READOUTS.

Jonathan Poyer

Sep 154 min read

Two Big Misses by Novartis (NVS) Has Shareholders Pushing for Board Overhaul

Two Big Misses by Novartis (NVS) Has Shareholders Pushing for Board Overhaul

Two Big Misses by Novartis (NVS) Has Shareholders Pushing for Board Overhaul

Jonathan Poyer

Sep 141 min read

AeroVironment (AVAV): $1.5 Billion Backlog — and LOCUST Goes International

AeroVironment (AVAV): $1.5 Billion Backlog — and LOCUST Goes International

AeroVironment (AVAV): $1.5 Billion Backlog — and LOCUST Goes International

Jonathan Poyer

Sep 111 min read

NOVARTIS (NVS): TWO PHASE 3 MISSES IN FOUR DAYS

NOVARTIS (NVS): TWO PHASE 3 MISSES IN FOUR DAYS

NOVARTIS (NVS): TWO PHASE 3 MISSES IN FOUR DAYS

Jonathan Poyer

Sep 93 min read

bottom of page